Business & Tech
Merck Announces $2.9 Billion Expansion In Montgomery Co.
New operations include state of the art robotics and AI-enabled drug research.

UPPER GWYNEDD TOWNSHIP, PA — Pharmaceutical giant Merck plans to invest an additional $2.9 billion in its Montgomery County operations over the next four years, state officials announced.
The state of Pennsylvania will pay $5 million to help Merck grow.
The expansion includes a new "state of the art" robotics and AI-enabled drug research and development at the campus in Upper Gwynedd and he Springhouse Innovation Park.
Find out what's happening in Montgomeryville-Lansdalefor free with the latest updates from Patch.
“Merck’s continued investment in Montgomery County is a testament to Pennsylvania’s strength as a global hub for life sciences, innovation, and advanced manufacturing,” said Rick Siger, the Secretary of Community and Economic Development. “The Commonwealth’s $5 million RACP investment is helping support projects that will strengthen Merck’s operations, advance the development and manufacturing of critical medicines and vaccines, and reinforce our competitive edge in an industry that is extremely important in Pennsylvania.”
Merck is the latest pharma industry to sign on long term plans and investments in Montgomery County. GlaxoSmithKline announced an $800 million expansion in Upper Merion earlier this year. That follows Johnson and Johnson's plans to build a $1 billion campus in Lower Gwynedd.
Find out what's happening in Montgomeryville-Lansdalefor free with the latest updates from Patch.
Merck's current West Point campus in Upper Gwynedd produces around 200 million doses of various vaccines per year, officials said.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.